Premedication with intravenous steroids does not influence the incidence of infusion reactions following infliximab infusions in pediatric inflammatory bowel disease patients-a case-control study.

Elsa A van WassenaerVeronique L MeesterAngelika KindermannBart G P KootMarc A BenningaTim G J de Meij

Published in: European journal of clinical pharmacology (2019)

The incidence of IR was low, and premedication with steroids did not decrease the incidence of IR in this cohort of PIBD patients receiving IFX. Our results indicate that PM with steroids is not indicated in PIBD to prevent IR.

Keyphrases

risk factors
end stage renal disease
ejection fraction
newly diagnosed
low dose
peritoneal dialysis
prognostic factors
risk assessment
ulcerative colitis
patient reported outcomes